“…Despite this, half of OPSCC diagnoses are made at stages III or IV, which have survival rates of 20-50% depending on the subsite (Gomez et al, 2010;Gomez et al, 2009). As well as improving survival rates (by up to 90% for early stage cancers) (Bagan, Sarrion & Jimenez, 2010), evidence suggests that an early diagnosis can also decrease the morbidity associated with treatment (Gomez et al, 2010).…”